Charles River Laboratories International Newswire

Charles River Laboratories International Newswire

Comprehensive Real-Time News Feed for Charles River Laboratories International.

Results 1 - 20 of 439 in Charles River Laboratories International

  1. Charles River Laboratories Intl. Inc (CRL) Earns "Buy" Rating from Jefferies Group LLCRead the original story w/Photo

    Wednesday Mar 22 | AmericanBankingNews.com

    Other analysts also recently issued reports about the stock. Evercore ISI upgraded shares of Charles River Laboratories Intl.

    Comment?

  2. Insider Buying: Creightons plc (CRL) Insider Acquires A 11,730 in StockRead the original story w/Photo

    Tuesday Mar 21 | Daily Political

    Creightons plc insider Nicholas OA'Shea acquired 69,000 shares of the business's stock in a transaction dated Thursday, March 16th. The shares were bought at an average cost of GBX 17 per share, for a total transaction of A 11,730 .

    Comment?

  3. Carl Announces Company Stock OptionsRead the original story

    Tuesday Mar 21 | World News Report

    Pursuant to the Company's Option Plan, Carl granted an aggregate of 684,939 stock options each exercisable into one common share of the Company at a price of $0.36 per Share to various employees, consultants and one officer exercisable until March 19, 2022. Of the 685,939 options, 54,939 options were granted to BDirect Online Communications Inc., a company with David Gregory Johnston, the Chief Executive Officer of Carl.

    Comment?

  4. Charles River Laboratories Intl. Inc (CRL) Receives Average...Read the original story w/Photo

    Tuesday Mar 21 | Daily Political

    ... that Charles River Laboratories Intl. will post $5.06 EPS for the current year. Charles River Laboratories International, Inc is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research ...

    Comment?

  5. Charles River Laboratories Intl. Inc (CRL) Receives Average Recommendation of a oeHolda from AnalystsRead the original story w/Photo

    Tuesday Mar 21 | The Breeze

    Complete the form below to receive the latest headlines and analysts' recommendationsfor Charles River Laboratories Intl. Inc with our free daily email newsletter:

    Comment?

  6. Davide Molho Sells 11,717 Shares of Charles River Laboratories Intl. Inc (CRL) StockRead the original story

    Tuesday Mar 21 | IntersportsWire

    ... 95.32% of the stock is owned by hedge funds and other institutional investors. Charles River Laboratories International, Inc is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research ...

    Comment?

  7. Nicholas O 'Shea Purchases 69,000 Shares of Creightons plc (CRL) StockRead the original story w/Photo

    Monday Mar 20 | The Breeze

    Complete the form below to receive the latest headlines and analysts' recommendationsfor Creightons plc with our free daily email newsletter: Creightons plc insider Nicholas OA'Shea acquired 69,000 shares of Creightons plc stock in a transaction dated Thursday, March 16th. The stock was bought at an average price of GBX 17 per share, for a total transaction of A 11,730 .

    Comment?

  8. Charles River Laboratories Intl. Inc (CRL) Insider Sells $3080852.58 in StockRead the original story

    Friday Mar 17 | The Oak Ridge Observer

    ... Liability Corp has 2,750 shares. 06/20/2016 - Credit Suisse began new coverage on Charles River Laboratories International, Inc. giving the company a "neutral" rating. The firm has a market capitalization of $4.33 billion, a price-to-earnings ratio ...

    Comment?

  9. Nicholas OA'Shea Buys 69,000 Shares of Creightons plc (CRL) StockRead the original story

    Friday Mar 17 | IntersportsWire

    Creightons plc insider Nicholas OA'Shea purchased 69,000 shares of the business's stock in a transaction on Thursday, March 16th. The shares were bought at an average price of GBX 17 per share, with a total value of A 11,730 .

    Comment?

  10. Jefferies Group LLC Reiterates Buy Rating for Charles River Laboratories Intl. IncRead the original story

    Thursday Mar 16 | AmericanBankingNews.com

    's stock had its "buy" rating reiterated by equities research analysts at Jefferies Group LLC in a research report issued to clients and investors on Thursday. Several other research analysts have also recently weighed in on CRL.

    Comment?

  11. Charles River to pay $1.8m to settle overbilling claimsRead the original story w/Photo

    Thursday Mar 16 | Drug Researcher

    The US Justice Department has announced Charles River Laboratories International Inc. will pay the US government $1.8m to settle claims that it violated the False Claims Act. Charles River contracts with the National Institutes of Health to develop, maintain, and distribute colonies of animals to the NIH.

    Comment?

  12. Charles River Laboratories Intl. Inc (CRL) Receives "Buy" Rating from Jefferies Group LLCRead the original story w/Photo

    Thursday Mar 16 | IntersportsWire

    's stock had its "buy" rating reissued by analysts at Jefferies Group LLC in a research note issued to investors on Thursday. CRL has been the topic of several other research reports.

    Comment?

  13. Biological Safety Testing Market Set to Witness an Uptick by 2021Read the original story w/Photo

    Wednesday Mar 15 | SBWire

    ... Top companies profiled in this report are: Charles River Laboratories International, Inc. Lonza Group Sigma-Aldrich Corporation Wuxi Pharmatech (Cayman), Inc. Merck & Co., Inc. SGS S.A. Avance Biosciences, Inc. Toxikon Corporation Cytovance ...

    Comment?

  14. Bioprocess Technology Market : New Market Research Report Announced;...Read the original story w/Photo

    Wednesday Mar 15 | SBWire

    Global Bioprocess Technology Market: Trends and Opportunities The bioprocess technology market is majorly gaining from the growth witnessed in the pharmaceutical and biotechnology industries. Given the scenario, the industry now witnesses rising research funding, novel drug launches, and increasing government support.

    Comment?

  15. Charles River Laboratories Intl. Inc (CRL) Insider David P. Johst Sells 34,593 Shares of StockRead the original story w/Photo

    Tuesday Mar 14 | IntersportsWire

    ... approximately $188,000. Institutional investors own 95.32% of the company's stock. Charles River Laboratories International, Inc is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research ...

    Comment?

  16. Charles River Labs settles with feds over NIH billing flapRead the original story

    Tuesday Mar 14 | Business Journal

    Wilmington-based Charles River Laboratories, one of the state's largest life science companies, has agreed to pay $1.8 million to settle allegations by U.S. prosecutors that it billed the National Institutes of Health for work on contracts that it didn't perform.

    Comment?

  17. Company to pay $1.8M to settle claims of overbillingRead the original story w/Photo

    Monday Mar 13 | WWLP

    The U.S. Department of Justice says a Massachusetts company has agreed to pay $1.8 million to settle claims it overbilled the federal government. Charles River Laboratories International Inc. was accused of violating the False Claims Act on contracts with the National Institutes of Health.

    Comment?

  18. Charles River re-ups Chiesi drug discovery contractRead the original story w/Photo

    Monday Mar 13 | Drug Researcher

    Charles River Laboratories has extended its integrated respiratory program with Chiesi Farmaceutici, through which it identifies and tests candidates for preclinical development. Parma, Italy-based Chiesi Farmaceutici SpA researches, develops, and markets drugs in the respiratory therapeutics, specialist medicine, and rare diseases areas.

    Comment?

  19. Charles River Laboratories International Inc. Agrees to Pay United...Read the original story

    Monday Mar 13 | PressReleasePoint

    Charles River Laboratories International Inc. has agreed to pay the U.S. government $1.8 million to settle claims that it violated the False Claims Act by improperly charging for labor and other associated costs that were not actually provided on certain National Institutes of Health contracts, the Justice Department announced today. Charles River is a for-profit corporation headquartered in Wilmington, Massachusetts.

    Comment?

  20. Charles River Laboratories Intl. Inc (CRL) Insider Sells $3,080,852.58 in StockRead the original story w/Photo

    Monday Mar 13 | Daily Political

    ... Hedge funds and other institutional investors own 95.32% of the company's stock. Charles River Laboratories International, Inc is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research ...

    Comment?